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Abstract: The use of titanium dioxide (TiO2) in various industrial applications (eg, production 
of paper, plastics, cosmetics, and paints) has been expanding thereby increasing the occupational 
and other environmental exposure of these nanoparticles to humans and other species. However, 
the health effects of exposure to TiO2 nanoparticles have not been systematically assessed even 
though recent studies suggest that such exposure induces inﬂ  ammatory responses in lung tissue 
and cells. Because the effects of such nanoparticles on human neural cells are unknown, we 
have determined the putative cytotoxic effects of these nanoparticles on human astrocytes-like 
astrocytoma U87 cells and compared their effects on normal human ﬁ  broblasts. We found that 
TiO2 micro- and nanoparticles induced cell death on both human cell types in a concentration-
related manner. We further noted that zinc oxide (ZnO) nanoparticles were the most effective, 
TiO2 nanoparticles the second most effective, and magnesium oxide (MgO) nanoparticles the 
least effective in inducing cell death in U87 cells. The cell death mechanisms underlying the 
effects of TiO2 micro- and nanoparticles on U87 cells include apoptosis, necrosis, and possibly 
apoptosis-like and necrosis-like cell death types. Thus, our ﬁ  ndings may have toxicological and 
other pathophysiological implications on exposure of humans and other mammalian species to 
metallic oxide nanoparticles.
Keywords: cytotoxicity of titanium dioxide micro- and nanoparticles, cytotoxicity of zinc oxide 
and magnesium oxide nanoparticles, human neural cells, human ﬁ  broblasts, nanotoxicity, cell 
death mechanisms
Introduction
The industrial use of metallic oxide nanoparticles in a wide variety of applications 
has been rapidly expanding in the last decade. Such applications include the use of 
silicon, titanium, iron, and other metallic oxide nanoparticles, thereby increasing the 
occupational and other environmental exposure of these nanoparticles to humans 
and other species (Lai et al 2007a). Nevertheless, the health effects of exposure of 
humans and other species to metallic oxide nanoparticles have not been systematically 
investigated as their impact on the environment has not been under the scrutiny of 
regulatory control (Oberdorster et al 2005; Lai et al 2007b).
Titanium dioxide (TiO2) has been increasingly employed in a variety of industrial 
applications including production of paper, plastics, cosmetics, and paints (Wang 
et al 2007) and TiO2 micro- and nanoparticles were classiﬁ  ed as comparatively inert 
(Chen and Fayerweather 1988; Bernard et al 1990; Hart and Hesterberg 1998). These 
ubiquitous applications lead to increasing human exposure to these nanoparticles. 
Garabrant and colleagues (1987) noted that pleural disease was present in 17% of the 
workers exposed to TiO2 and was associated with the duration of work in titanium 
manufacturing, even though the health risk resulting from this increased exposure International Journal of Nanomedicine 2008:3(4) 534
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to such nanoparticles both in natural as well as industrial 
environments has not been comprehensively or systemati-
cally assessed. Nevertheless, recent in vivo studies in animals 
have pointed to the possibilities that inhalation and other lung 
exposure to TiO2 particles can induce inﬂ  ammatory responses 
in lung tissue and even cytotoxicity in lung cells although the 
degree of inﬂ  ammatory responses and cytotoxicity elicited 
depends critically on particle size and its surface chemistry 
(Rehn et al 2003; Dick et al 2003; Renwick et al 2004; 
Warheit et al 2005; Monteiller et al 2007; Warheit et al 2007). 
However, these criteria are still somewhat controversial and 
remain to be resolved (Renwick et al 2001; Rehn et al 2003; 
Monteiller et al 2007; Warheit et al 2007).
The few studies on the cytotoxic effects of TiO2 nanopar-
ticles on human cell types have been mainly focused on 
lung or related epithelial cells. For example, Stearns and 
colleagues (2001) demonstrated human epithelial A549 cells 
were able to take up TiO2 nanoparticles (50 nm diameter) 
by endocytosis when exposed to them at 40 μg/mL. 
Subsequently, Singh and colleagues (2007) found that these 
human lung epithelial (A549) cells could take up a range 
of TiO2 nanoparticles (20–300 nm) and exposure to these 
nanoparticles triggered inﬂ  ammatory responses from the cells. 
In parallel, Monteiller and colleagues (2007) noted similar 
inﬂ  ammatory responses elicited from A549 cells by exposure 
to TiO2 nanoparticles and exposure to TiO2 nanoparticles also 
induced dose-related apoptotic damage in such cells (Park 
et al 2007). Furthermore, anatase TiO2 nanoparticles were 
more cytotoxic than rutile TiO2 nanoparticles to the A549 
cells (Sayes et al 2006). Exposure of BEAS-2B cells, another 
human bronchial epithelial cell line, to TiO2 nanoparticles 
likewise resulted in oxidative damage to those cells (Gurr 
et al 2005). Furthermore, exposure to TiO2 nanoparticles 
(100 nm in diameter) induced genotoxicity and cytotoxicity 
in cultured human lymphoblastoid (WIL2-NS) cells (Wang 
et al 2007).
Consistent with the ﬁ  ndings of effects of TiO2 nanoparticles 
on human lung epithelial cells are the limited investigation 
employing non-human mammalian cells. Exposure of 
Syrian hamster embryo ﬁ  broblasts to ultraﬁ  ne TiO2 particles 
(20 nm) resulted in micronuclei and apoptosis in those cells 
(Rahman et al 2002) and TiO2 nanoparticles (40 nm) also 
induced cytotoxicity in rat liver cells (Hussain et al 2005). 
Nevertheless, the effects of TiO2 nanoparticles on human or 
non-human mammalian neural cells are largely unknown 
(Lai et al 2007a, 2007b).
Airborne toxic metallic substances can enter the brain 
directly via retrograde transport through the olfactory 
nerve and olfactory bulb and/or via transport across the 
blood-brain barrier subsequent to lung absorption (Lai et al 
2000). Astrocytes form end-feet around the brain capillary 
endothelium, which is the main cellular component of the 
blood-brain barrier (Ballabh et al 2004). Thus, metallic oxide 
nanoparticles could reach the brain via these two routes. Again, 
the putative cytotoxic effects of such nanoparticles on neural 
cells have not been elucidated (Lai et al 2007a, 2007b).
We hypothesized that TiO2 nanoparticles can exert 
differential cytotoxic effects on various human cell types. 
Thus, to test our hypothesis, this study was initiated to 
compare the putative cytotoxic effects of TiO2 micro- and 
nanoparticles on human astrocytoma (astrocytes-like) U87 
cells and on normal human ﬁ  broblasts employing established 
cytotoxicity testing approaches (Rose et al 1993; Lai et al 
1999, 2001; Malthankar et al 2004; Puli et al 2006; Dukhande 
et al 2006). Furthermore, we have compared the effects of 
magnesium oxide (MgO) and zinc oxide (ZnO) nanoparticles 
with those of TiO2 nanoparticles on U87 cells to determine 
if the effects of metallic oxide nanoparticles of essential 
elements (eg, Mg and Zn) are similar to those of metallic 
oxide nanoparticles of nonessential elements (eg, Ti).
Materials and methods
Materials
Titanium dioxide (TiO2) microparticles (STREM Chemicals, 
Newburyport, MA, USA; Cat. #93-2206; synonym, 
beta-Rutile; 99% pure; 1–1.3 μ), TiO2, anatase, nanoparticles 
(Sigma-Aldrich, St. Louis, MO, USA; Cat. #637254; 
nanopowder, 25 nm particle size, 99.7% (metals basis)), MgO 
nanopowder (Sigma-Aldrich; Cat. #549649; nanopowder, 
50 nm particle size), and ZnO nanopowder (Sigma-Aldrich; 
Cat. #544906; nanopowder, 100 nm particle size) were 
dispersed in 100 mL of sterile saline in a sealed conical ﬂ  ask and 
the suspension stirred at ambient temperature overnight before 
being employed to be diluted to the speciﬁ  ed concentrations 
for treatment of cells (see below). Dulbecco’s minimum 
essential medium (DMEM) and other chemicals (usually of 
analytical grade) were purchased from Sigma-Aldrich. The 
ApoScreenTM Annexin V-FITC Kit (Cat. #10010-02) was 
purchased from Southern Biotechnology Associates, Inc. 
(Birmingham, AL 35260, USA).
Cells and culture conditions
Human astrocytoma U87 (astrocytes-like) cells and human 
ﬁ  broblasts (HFF-1) were obtained from ATCC (Manassas, 
VA, USA) and were cultured in DMEM, supplemented with 
10% (v/v) (and in the case of HFF-1 cells, 15% (v/v)) fetal International Journal of Nanomedicine 2008:3(4) 535
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bovine serum and were incubated at 37 °C and 5% (v/v) CO2 
as described previously (Malthankar et al 2004).
Cell viability assay
Cellular viability was determined using the MTT assay 
(Malthankar et al 2004). Cells were seeded with equal density 
in each well of 96 well plates and allowed to attach to the 
bottom of each well for 60–90 minutes. Cells were then treated 
in 96-well plates with speciﬁ  ed concentrations of TiO2 micro- 
or nanoparticles or ZnO nanoparticles or MgO nanoparticles 
for 48 hours at 37 °C. At the end of the treatment period, 
MTT dye (0.5% (w/v) in phosphate-buffered saline) was 
added to each well and the plates (set one) were incubated for 
another 4 hours at 37 °C. Purple colored insoluble formazan 
crystals in viable cells were dissolved using dimethyl 
sulfoxide (DMSO, 100 μL per well). To prevent the micro- 
and nanoparticles from interfering with this assay (data not 
shown), the formazan material dissolved in DMSO in each 
well of each plate was quantitatively transferred to an empty 
well in another plate (set two) while the material in DMSO 
from a well with micro- or nanoparticles only (ie, without 
cells) served as the corresponding control. Subsequently, the 
absorbance of the content of each well in each plate (set two) 
was measured at 567 nm using a multi-detection microplate 
reader (Bio-Tek Synergy HT, Winooski, VT, USA).
Cellular morphology
The putative changes in the morphology of U87 cells 
treated with speciﬁ  ed concentrations of TiO2 micro- or 
nanoparticles for 48 hours at 37 °C as described above were 
compared to that of corresponding untreated cells by light 
microscopy. Bright ﬁ  eld images of cells were acquired using 
a Leica light microscope (Leica DM IRB, Bannockburn, IL, 
USA) equipped with a digital camera (Leica DFC 300FX) 
(Dukhande et al 2006).
Cell damage and assay for necrosis
Cell damage was determined by monitoring lactate dehydroge-
nase (LDH) release from cells into the culture medium: LDH 
release from cells is a marker of necrotic cell damage and cell 
death (Rose et al 1993; Lai et al 1999, 2001). U87 cells were 
cultured in DMEM in 75 cm2 ﬂ  asks until they were ∼70% 
conﬂ  uent and then treated with different concentrations of TiO2 
micro- or nanoparticles for 48 hours at 37 °C. Subsequently, 
the culture medium from each ﬂ  ask was removed and kept 
at −70 °C until they were used for assaying LDH activity 
therein. LDH activity released by cells into the culture medium 
was assayed by the procedure of Clark and Lai (1989).
Determination of necrotic 
and apoptotic cells
U87 cells were seeded at 5,000 cells per well onto a 48-well 
plate and were allowed 2–4 hours for them to attach to the 
bottom of the well. The cells were then treated with TiO2 
micro- or nanoparticles at 1, 10, or 50 μg/mL for 48 hours 
at 37 °C as described above. Then the medium was removed 
from each well and the cell washed with phosphate-buffered 
saline. Subsequently, 200 μl of the binding buffer from the 
ApoScreenTM Annexin V-FITC Kit (Southern Biotechnology 
Associates, Inc.), followed by 10 μl of Annexin-V and 10 μl 
of propidium iodide (PI) from the same kit. After adding 
the dyes into each well, the plate was incubated at 37 °C for 
30 minutes. Afterwards, images of ﬂ  uorescent cells were 
captured using a ﬂ  uorescence microscope (Leica DM IRB) 
equipped with a digital camera (Leica DFC 300 FX). The 
color photomicrographs were digitally converted to grey-scale 
images for presentation herein. The green Annexin-V dye 
stained apoptotic cells whereas red-ﬂ  uorescent PI dye stained 
necrotic cells (White et al 2003).
Statistical analyses of data
Results are presented as mean ± standard error of the mean 
(SEM) of 6–9 determinations in each experiment. Each 
experiment was performed at least three times. Data analysis 
was carried out by one-way analyses of variance (ANOVA), 
followed by post-hoc Student–Newman–Keuls test for 
multiple comparisons using the software KaleidaGraph version 
4 (Synergy Software, Reading, PA, USA). Signiﬁ  cance level 
was set at P  0.05.
Results
Effects of TiO2 micro- and nanoparticles 
on survival of human astrocytoma 
(astrocytes-like) U87 cells
Exposure of U87 cells for 48 hours to both TiO2 micro- and 
nanoparticles at concentrations below 1.0 μg/mL did not affect 
their survival as determined by the MTT assay (Figure 1). 
However, at concentrations higher than 1 μg/mL, both TiO2 
micro- and nanoparticles induced concentration-related (and 
time-dependent up to 72 hours; data not shown) decrease in 
survival of U87 cells, with similar IC50 (ie, concentration 
that gave rise to 50% decrease in cell survival) values of 
∼40 and 34 μg/mL, respectively (Figure 1). At the highest 
concentration of both micro- and nanoparticles employed 
(ie, 100 μg/mL), U87 cell survival decreased to less than 
30% of those of untreated cells (ie, control) (Figure 1). International Journal of Nanomedicine 2008:3(4) 536
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It is interesting to note that irrespective of their sizes, the 
dose-effect relations of micro- and nanoparticles on U87 
cells were very similar.
Effects of ZnO and MgO nanoparticles 
on survival of human astrocytoma 
(astrocytes-like) U87 cells
To assess if other metallic oxide nanoparticles may exert 
cytotoxicity on human neural cells similar to those of TiO2 
micro- and nanoparticles, we also studied the effects of 
nanoparticles of two oxides of essential metals, namely ZnO 
and MgO, on U87 cells. Exposure of these cells to ZnO for 
48 hours at concentrations higher than 1 μg/mL induced a 
concentration-related decreases in cell survival, with an IC50 
of ∼11 μg/mL (Figure 2); at concentrations of ZnO nanopar-
ticles higher than 20 μg/mL, cell survival decreased to less 
than 5% of that of untreated (ie control) cells (Figure 2). 
In contrast with the effect of ZnO nanoparticles, treatment 
of U87 cells with MgO nanoparticles for 48 hours did not 
signiﬁ  cantly decrease their survival until the concentrations 
were higher than 50 μg/mL (Figure 2). Nevertheless, even at 
the highest concentration employed (ie, 100 μg/mL), MgO 
nanoparticles only did induce approximately 35% decrease in 
U87 cell survival, indicating that at the concentration range 
employed, MgO nanoparticles were less cytotoxic to these 
cells than ZnO nanoparticles (Figure 2).
Effects of TiO2 micro- and nanoparticles 
on survival of human ﬁ  broblasts (HFF-1)
To determine if the effects of TiO2 micro- and nanoparticles 
on neural cells were similar to their effects on nonneural cells, 
we also examined the effects of these metallic oxide micro- 
and nanoparticles on normal human ﬁ  broblasts (HFF-1 cells). 
Exposure of HFF-1 cells for 48 hours to both TiO2 micro- and 
nanoparticles induced signiﬁ  cant decreases in cell survival at 
concentrations higher than 1 μg/mL (Figure 3). At concentra-
tions between 1 and 10 μg/mL, TiO2 nanoparticles were more 
potent in lowering the survival of these cells whereas when 
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Figure 1 Effects of TiO2 micro- and nanoparticles on survival of human astrocytoma (astrocytes-like) U87 cells.
Notes:  Values are mean ± SEM of 6–9 determinations. U87 cells treated with TiO2 microparticles are marked with open squares and those treated with TiO2 nanoparticles 
are marked with open circles. Values marked with a and b are signiﬁ  cantly different (p  0.05, by ANOVA and post-hoc Student–Newman–Keuls test) from corresponding 
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Abbreviations: ANOVA, analysis of variance; SEM, standard error of mean; TiO2, titanium dioxide.International Journal of Nanomedicine 2008:3(4) 537
TiO2 nanoparticles and neural cell cytotoxicity
120
100
80
60
40
20
0
0.1 1 10 100
Concentration (μg/mL)
C
e
l
l
 
s
u
r
v
i
v
a
l
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
b b b
b
b
a
a
MgO nanoparticles
ZnO nanoparticles
Figure 2 Effects of ZnO and MgO nanoparticles on human astrocytoma (astrocytes-like) U87 cells.
Notes:  Values are mean ± SEM of 6–9 determinations. U87 cells treated with ZnO nanoparticles are marked with open squares and those treated with MgO nanoparticles 
are marked with open circles. Values marked with a and b are signiﬁ  cantly different (p  0.05, by ANOVA and post-hoc Student–Newman–Keuls test) from corresponding 
mean value in control (ie, untreated) cells.
Abbreviations: ANOVA, analysis of variance; MgO, magnesium oxide; SEM, standard error of mean; ZnO, zinc oxide.
the concentrations were increased beyond 10 μg/mL, both the 
micro- and the nanoparticles were equally effective in lower-
ing the survival of the HFF-1 cells, except at the highest level 
employed (ie, 100 μg/mL), where again the nanoparticles were 
more effective than the microparticles in lowing the survival 
of these cells (Figure 3). When these cells were treated with 
TiO2 micro- and nanoparticles at 100 μg/mL for 48 hours, their 
survival decreased to less than 40% and 30%, respectively, of 
that of untreated (ie, control) HFF-1 cells (Figure 3). Neverthe-
less, irrespective of their sizes, the IC50 values for both TiO2 
micro- and nanoparticles in lowering the survival of HFF-1 
cells were about the same: they were ∼40 μg/mL (Figure 3).
Effects of TiO2 micro- and nanoparticles 
on lactate dehydrogenase release from 
human astrocytoma (astrocytes-like) 
U87 cells into the medium
To further elucidate the cytotoxic effects of TiO2 micro- and 
nanoparticles on U87 cells, we determine the effects of these 
two types of particles on inducing lactate dehydrogenase 
(LDH) release from U87 cells into the medium because 
LDH release from cells is a marker of necrotic cell damage 
and cell death (Rose et al 1993; Lai et al 1999, 2001). 
Treatment of U87 cells with TiO2 micro- or nanoparticles at 
1 and 10 μg/mL did not induce any increases in LDH from 
these cells (data not shown). Treatment of these cells with 
TiO2 micro- or nanoparticles at 50 μg/mL for 48 hours only 
elicited modest increases (25%) in LDH release from these 
cells (data not shown), suggesting that even at this higher 
concentration, both TiO2 micro- and nanoparticles only 
induced minimal necrotic damage to these cells.
Cell death mechanisms underlying the 
effects of TiO2 micro- and nanoparticles 
on human astrocytoma (astrocytes-like) 
U87 cells
To further elucidate the cell death mechanism(s) underly-
ing the effects of these micro- and nanoparticles on human International Journal of Nanomedicine 2008:3(4) 538
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astrocytoma (astrocytes-like) U87 cells, we examined the 
cellular morphology of these cells under bright ﬁ  eld light 
microscopy after the cells had been exposed to speciﬁ  ed 
concentration of TiO2 micro- or nanoparticles. Furthermore, 
employing ﬂ  uorescence microscopy, we also examined the 
treated cells stained with PI and Annexin-V. We chose the 
concentrations of TiO2 micro- and nanoparticles at 1, 10, and 
50 μg/mL because they fell in the range that was above and 
below the respective IC50 values of the particles in inducing 
cell death (see Figure 1).
As noted under bright ﬁ  eld microscopy, the control (ie, 
untreated) U87 cells showed “healthy” morphology with 
one or more processes extended from their cell bodies 
(Figure 4A). After treatment with either TiO2 microparticles 
(Figure 4B) or nanoparticles (Figure 4E) at 1 μg/mL for 
48 hours, the nuclei of the treated U87 cells became more 
prominent while there were fewer processes extended from 
their cell bodies. At the same time, the TiO2 micropar-
ticles and nanoparticles appeared to aggregate and some 
aggregated on or around the U87 cells (Figures 4B and 4E). 
After U87 cells had been treated with 10 and 50 μg/mL of 
TiO2 microparticles (Figures 4C and 4D) or nanoparticles 
(Figures 4F and 4G), few intact cells were observed although 
some particle aggregates were noted to be around or on 
cells. Both micro- and nanoparticles appeared to form both 
small and larger aggregates, the number of which appeared 
to increase as the particle concentration was increased 
(Figures 4C, 4D, 4F, and 4G). Thus, the bright ﬁ  eld micros-
copy data are consistent with cell survival data (Figure 1), 
suggesting that when U87 cells were treated with increas-
ing concentrations of TiO2 microparticles or nanoparticles, 
there was a progressive decrease in the number of live 
U87 cells.
As noted under ﬂ  uorescence microscopy, there were 
very few control (ie untreated) U87 cells stained with PI 
(Figure 5A), indicating that there were very few necrotic 
cells among the population of untreated U87 cells examined. 
After U87 cells had been treated with progressively increased 
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Figure 3  Effects of TiO2 micro- and nanoparticles on survival of human ﬁ  broblasts (HFF-1).
Notes: Values are mean ± SEM of 6–9 determinations. HFF-1 cells treated with TiO2 microparticles are marked with open squares and those treated with TiO2 nanoparticles 
are marked with open circles. Values marked with a and b are signiﬁ  cantly different (p  0.05, by ANOVA and post-hoc Student–Newman–Keuls test) from corresponding 
mean value in control (ie, untreated) cells.
Abbreviations: ANOVA, analysis of variance; SEM, standard error of mean;   TiO2, titanium dioxide.International Journal of Nanomedicine 2008:3(4) 539
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Figure 4 Cellular morphology of human astrocytoma (astrocytes-like) U87 cells after exposure to TiO2 microparticles or nanoparticles.
Notes: U87 cells were treated with TiO2 microparticles or nanoparticles for 48 hours and then examined with bright ﬁ  eld light microscopy at a magniﬁ  cation of 100. The 
treatments were: A) control (ie, untreated) U87 cells; B) cells treated with 1 μg/mL TiO2 microparticles; C) cells treated with 10 μg/mL TiO2 microparticles; D) cells treated 
with 50 μg/mL TiO2 microparticles; E) cells treated with 1 μg/mL TiO2 nanoparticles; F) cells treated with 10 μg/mL TiO2 nanoparticles; and G) cells treated with 50 μg/mL 
TiO2 nanoparticles.
Abbreviation: TiO2, titanium dioxide.International Journal of Nanomedicine 2008:3(4) 540
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concentrations of TiO2 microparticles (1, 10, or 50 μg/mL) for 
48 hours, the number of cells stained with PI progressively 
increased (Figures 5B–5D), suggesting that the number of 
necrotic cells increased with increases in treatment levels. 
Similarly, the number of cells stained with PI likely pro-
gressively increased (Figures 5E–5G) with increases in the 
treatment level of TiO2 nanoparticles (1, 10, or 50 μg/mL 
for 48 hours) although the effects of the nanoparticles were 
somewhat less marked than those of the microparticles 
(Figures 5B–5D). It should be pointed out that we noticed 
that both TiO2 microparticles and nanoparticles interacted 
with the PI dye to yield some ﬂ  uorescence in the absence of 
U87 cells, although their ﬂ  uorescence was minimal (data not 
shown) compared those noted in the treated cells.
As observed under fluorescence microscopy, very 
few control (ie, untreated) U87 cells were stained with 
Annexin-V (Figure 6A), indicating that there were very few 
apoptotic cells within that population. After U87 cells had 
been treated with progressively increased concentrations 
of TiO2 microparticles (1, 10, or 50 μg/mL) for 48 hours, 
the number of cells stained with Annexin-V progressively 
increased (Figures 6B–6D), suggesting that the number 
of apoptotic cells increased with increases in treatment 
levels. It is interesting to note that not all the treated cells 
showed uniformed staining although the staining intensity 
increased as the treatment level increased (Figures 6B–6D) 
suggesting that the microparticle-induced apoptosis was not 
synchronized in those populations of U87 cells. Similarly, 
after U87 cells had been treated with progressively increased 
concentrations of TiO2 nanoparticles (1, 10, or 50 μg/mL) 
for 48 hours, the number of cells stained with Annexin-V 
progressively increased (Figures 6E–6G), suggesting that 
the number of apoptotic cells increased with increases in 
treatment levels. However, the level of Annexin-V staining 
in the nanoparticles-treated cells was less marked compared 
to those in cells treated with corresponding levels of mic-
roparticles (Figures 6B–6D). Again, we noticed that both 
TiO2 microparticles and nanoparticles interacted with the 
Annexin-V dye to yield some ﬂ  uorescence in the absence of 
U87 cells, although their ﬂ  uorescence was minimal (data not 
shown). Furthermore, it was interesting to observe that many 
U87 cells treated with TiO2 microparticles or nanoparticles 
stained with Annexin-V also co-stained with PI (compare 
Figures 5 and 6) while in the same ﬁ  eld there were few 
treated cells that stained only with Annexin-V or PI, sug-
gesting either apoptosis and necrosis mechanisms were co-
occurring in those cells or those cells exhibited another cell 
death mechanism that shares some common features with 
apoptosis and necrosis (ie, hybrid mechanism; Bröker et al 
2005; Wei et al 2006; Golstein and Kroemer 2007).
Discussion
To our knowledge our studies are the ﬁ  rst to demonstrate the 
cytotoxic effects of TiO2 micro- and nanoparticles on human 
neural cells (namely U87 astrocytoma cells) and to compare 
those effects with the effects of ZnO and MgO nanoparticles 
on the same cell type. At the same time we also contrasted the 
cytotoxic effects of TiO2 micro- and nanoparticles on human 
U87 cells (astrocytes-like) and on normal human ﬁ  broblasts 
(HFF-1 cells). Furthermore, we have also determined the 
cell death mechanisms underlying the cytotoxic effects 
of TiO2 micro- and nanoparticles on U87 cells. We found 
that TiO2 micro- and nanoparticles appeared to induce U87 
cells to undergo both apoptosis and necrosis or a cell death 
mechanism that may contain features of both apoptosis and 
necrosis (see below).
Because the putative cytotoxic effects of TiO2 micro- and 
nanoparticles on human cells (especially human neural cells) 
have not been systematically elucidated, with the exception 
of human lung epithelial (A549) cells (Stearns et al 2001; 
Singh et al 2007; Monteiller et al 2007; Park et al 2007), we 
have examined the effects of TiO2 micro- and nanoparticles 
on human astrocytoma (astrocytes-like) U87 cells and normal 
human ﬁ  broblasts (HFF-1 cells) employing the MTT cell 
survival assay (Lai et al 1999, 2001; Malthankar et al 2004; 
Puli et al 2006; Dukhande et al 2006). Our results demon-
strate that in a concentration range similar to those employed 
in human lung (A549) cells (Stearns et al 2001), treatment 
of human astrocytoma (astrocytes-like) U87 cells with TiO2 
microparticles or nanoparticles at levels higher than 1 μg/mL 
for 48 hours induced a concentration-related lowering of cell 
survival, with IC50 values of 30–40 μg/mL (Figure 1). At the 
highest level of both TiO2 microparticles and nanoparticles 
investigated (ie, 100 μg/mL), the survival of U87 cells 
decreased to less than 30% (Figure 1). Similarly, exposure 
of normal human ﬁ  broblasts (HFF-1 cells) to both TiO2 mic-
roparticles and nanoparticles in the same concentration range 
also induced a dose-related decrease in cell survival, with 
IC50 values of ∼40 μg/mL (Figure 3) although at the lower 
concentration range of 1 to 10 μg/mL, TiO2 nanoparticles 
were more effective than the microparticles in lowering 
the survival of human ﬁ  broblasts (HFF-1 cells) (Figure 3). 
Thus, these results suggest that both TiO2 microparticles and 
nanoparticles, despite the difference in their sizes, are equally 
effective in inducing cell death in human neural (ie, U87) 
cells and normal ﬁ  broblasts (Figures 1 and 3). While the International Journal of Nanomedicine 2008:3(4) 541
TiO2 nanoparticles and neural cell cytotoxicity
Figure 5 Increases in PI-stained cells after exposure of human astrocytoma (astrocytes-like) U87 cells to TiO2 microparticles or nanoparticles.
Notes: U87 cells were treated with TiO2 microparticles or nanoparticles for 48 hours, then stained with PI, and the stained cells were photographed at a magniﬁ  cation of 
100. The treatments were: A) control (ie, untreated) U87 cells; B) cells treated with 1 μg/mL TiO2 microparticles; C) cells treated with 10 μg/mL TiO2 microparticles; D) cells 
treated with 50 μg/mL TiO2 microparticles; E) cells treated with 1 μg/mL TiO2 nanoparticles; F) cells treated with 10 μg/mL TiO2 nanoparticles; and G) cells treated with 
50 μg/mL TiO2 nanoparticles.
Abbreviations: PI, propidium iodide; TiO2, titanium dioxide.International Journal of Nanomedicine 2008:3(4) 542
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Figure 6 Increases in Annexin-V-stained cells after exposure of human astrocytoma (astrocytes-like) U87 cells to TiO2 microparticles or nanoparticles.
Notes: U87 cells were treated with TiO2 microparticles or nanoparticles for 48 hours, then stained with Annexin-V, and the stained cells were photographed at a magniﬁ  cation 
of 100. The treatments were: A) control (ie, untreated) U87 cells; B) cells treated with 1 μg/mL TiO2 microparticles; C) cells treated with 10 μg/mL TiO2 microparticles; 
D) cells treated with 50 μg/mL TiO2 microparticles; E) cells treated with 1 μg/mL TiO2 nanoparticles; F) cells treated with 10 μg/mL TiO2 nanoparticles; and G) cells treated 
with 50 μg/mL TiO2 nanoparticles. Cells marked with  or  were co-stained with both Annexin-V and PI.
Abbreviations: PI, propidium iodide; TiO2, titanium dioxide.International Journal of Nanomedicine 2008:3(4) 543
TiO2 nanoparticles and neural cell cytotoxicity
cytotoxic effects of TiO2 microparticles and nanoparticles 
on human cell types other than those discussed above are 
largely unknown, there is one study noting that exposure to 
TiO2 nanoparticles induced cytotoxicity and genotoxicity in 
human lymphoblastoid (WIL2-NS) cells (Wang et al 2007). 
Furthermore, Hussain and colleagues (2005) reported TiO2 
nanoparticles induced cytotoxicity in rat liver cells.
As far as we are aware, we are also the ﬁ  rst to compare 
the cytotoxic effects of metallic oxide nanoparticles of 
essential metals (namely zinc and magnesium) with those of 
a nonessential metal (ie, Ti) on human neural (namely U87 
astrocytoma) cells. It is interesting to note that of the three 
metallic oxide nanoparticles, ZnO nanoparticles were the 
most effective (Figure 3), TiO2 nanoparticles were the next 
most effective (Figure 1), and MgO nanoparticles the least 
effective (Figure 3) in inducing cell death in U87 cells. In 
this context, it is relevant to observe that, in contrast with 
their effect on human neural U87 cells, ZnO nanoparticles 
(∼13 nm) are not effective in lowering the survival of primary 
human T cells at concentrations 5 mM (Reddy et al 2007). 
Clearly, additional work is required to further elucidate the 
cytotoxic effects of ZnO and other metallic oxide nanopar-
ticles on these and other human cell types.
Because cell death mechanisms underlying the effects 
of TiO2 microparticles and nanoparticles on neural cells are 
unknown, we have investigated these putative mechanisms 
in human astrocytoma (astrocytes-like) U87 cells. We found 
that a fraction of U87 cells treated with TiO2 microparticles 
or nanoparticles showed Annexin-V staining, a marker 
of apoptosis, and the cellular staining was increased with 
increases in the treatment concentrations of the micropar-
ticles or nanoparticles (Figure 6). This ﬁ  nding indicates that 
treatment of U87 cells with either TiO2 microparticles or 
nanoparticles, irrespective of their sizes, induces apoptosis 
in those cells: this observation is consistent with that of Park 
and colleagues (2007) who showed that treatment of human 
lung epithelial (A549) cells with TiO2 nanoparticles induce 
dose-related apoptotic damage in those cells.
In our studies (Figure 5), we also noted that a fraction 
of U87 cells treated with TiO2 microparticles or nanopar-
ticles showed PI staining, a marker of necrosis, and the 
cellular staining was increased with increases in the treat-
ment concentrations of the microparticles or nanoparticles 
(Figure 5). Thus, this observation demonstrates that treat-
ment with TiO2 microparticles or nanoparticles also induces 
necrotic cell death in human neural (ie, U87) cells. However, 
a third and larger fraction of U87 cells treated with TiO2 mic-
roparticles or nanoparticles showed co-staining with both PI 
and Annexin-V (compare Figures 5 and 6). There are several 
mechanistic explanations to account for the co-staining of PI 
and Annexin-V in the treated U87 cells. (i) Both apoptosis 
and necrosis could be co-occurring in the U87 cells treated 
with TiO2 microparticles or nanoparticles. Co-existence of 
apoptosis and necrosis in neural cells is known to occur: for 
example, in the developing brain, focal ischemia induces cell 
death with overt apoptotic characteristics co-existing with 
some features of necrosis (Wei et al 2006). (ii) Paraptosis, a 
new type of cell death independent of caspases (Sperandio 
et al 2000; Bröker et al 2005), could occur in the U87 cells 
treated with TiO2 microparticles or nanoparticles because 
paraptotic cells are stained with PI (Sperandio et al 2000). 
(iii) The apoptosis-like and necrosis-like programmed cell 
death as postulated by Bröker and colleagues (2005) could 
occur in the U87 cells treated with TiO2 microparticles or 
nanoparticles because of our observation that the cells were 
co-stained with PI and Annexin-V, yet the lactate dehydro-
genase release from such cells were minimal (see Results 
section above). (iv) There remains the possibility that we 
may be encountering a totally new mode of cell death mecha-
nism in the U87 cells treated with TiO2 microparticles or 
nanoparticles. After all, it has become increasingly clear that 
the “classical” distinction of three cell death types – type I 
(apoptosis), type II (autophagy), and type III (necrosis) – is 
inadequate to account for all the observed phenomena of 
cell death (Bröker et al 2005; Golstein and Kroemer 2007). 
Consequently, only additional studies will elucidate as to 
which of the cell death mechanisms proposed above can 
accurately depict the mechanisms induced in U87 cells by 
treatment with TiO2 microparticles or nanoparticles.
Conclusion and implications
Our studies are the ﬁ  rst to demonstrate that exposure of 
human neural (ie, astrocytoma U87) cells to TiO2 micro- and 
nanoparticles induces a concentration-related increases in cell 
death in this cell type. We also found similar dose-related 
effects of these micro- and nanoparticles in inducing cell 
death in normal human ﬁ  broblasts (HFF-1 cells). In compar-
ing the effects of metallic oxide nanoparticles of essential 
metals (ie, ZnO and MgO) and nonessential metals (ie, TiO2), 
we noted ZnO nanoparticles are the most effective, TiO2 
nanoparticles the second most effective, and MgO nanopar-
ticles the least effective in inducing decreases in survival of 
human neural (ie astrocytoma U87) cells.
We observed that treatment of human astrocytoma 
(astrocytes-like) U87 cells with TiO2 microparticles or 
nanoparticles induces several modes of cell death in these cells, International Journal of Nanomedicine 2008:3(4) 544
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including apoptosis, necrosis, and possibly a “new” type of cell 
death that is apoptosis-like and necrosis-like. Thus, these inter-
esting phenomena merit further investigation to elucidate the 
underlying pathophysiological and molecular mechanisms.
As alluded to above, the industrial use of metallic oxide 
nanoparticles (including those of TiO2) in wide diversity of 
applications has been expanding exponentially, leading to 
increasing occupational and other environmental exposure 
of these nanoparticles to human and other species. Because 
airborne toxic metallic substances can enter the brain directly 
via retrograde transport through the olfactory nerve into the 
rest of the brain and/or via transport across the blood-brain 
barrier, the results of our studies may have toxicological 
and other pathophysiological implications in exposure of 
human and other mammalian species to TiO2 micro- and 
nanoparticles in particular, and to metallic oxide nanopar-
ticles in general. Consequently, metallic oxides such as TiO2, 
that is used in dental and other implants (Wennerberg et al 
1995; Rasmusson et al 2005) because the material appears 
to be biologically compatible, may not be as benign as one 
previously presupposed. Clearly, this area of nanotoxicity 
deserves further systematic investigation.
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